Two Sigma Investments’s Translational Development Acquisition Corp Units TDACU Stock Holding History

Two Sigma Investments’s Portfolio TDACU Stock Details TDACU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-133,325	Closed	-$1.37M	–	4009
2025 Q2	$1.37M	Hold	133,325	–	–	﹤0.01%	2067
2025 Q1	$1.35M	Hold	133,325	–	–	﹤0.01%	1992
2024 Q4	$1.34M	Buy	+133,325	New	+$1.34M	﹤0.01%	1985

Other funds holding TDACU

AIMCA

Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $17.9B AUM 27.56% 1-Year Est. Return

Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

RCM

Rivernorth Capital Management West Palm Beach, Florida $2.1B AUM 2.15% 1-Year Est. Return

YCM

Yakira Capital Management Westport, Connecticut $351M AUM 21.82% 1-Year Est. Return

FTUS

Flow Traders U.S. New York $2.43B AUM 44.44% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Two Sigma Investments's TDACU Position: Q3 2025 in Review

Two Sigma Investments sold out of Translational Development Acquisition Corp Units (TDACU) in Q3 2025, closing a stake of 133,325 shares — an estimated $1.37M sold.

Two Sigma Investments first reported a position in TDACU in Q4 2024 and held it in 3 quarters. The position peaked at $1.37M in Q2 2025. 7 funds tracked by Wall St. Rank hold TDACU as of Q3 2025.

Two Sigma Investments reported no remaining Translational Development Acquisition Corp Units position as of Q3 2025 after selling out during the quarter.
Two Sigma Investments sold 133,325 Translational Development Acquisition Corp Units shares in Q3 2025, an estimated $1.37M.
Two Sigma Investments first reported a position in Translational Development Acquisition Corp Units in Q4 2024 and held it in 3 quarters.
Two Sigma Investments's Translational Development Acquisition Corp Units position peaked at $1.37M in Q2 2025.
7 funds tracked by Wall St. Rank held Translational Development Acquisition Corp Units as of Q3 2025.

Based on Two Sigma Investments's 13F filing for Q3 2025, filed 14 Nov 2025.